Valerie Barnett Cytek Biosciences, Inc. (CTKB) insider trading activity

Valerie Barnett is CHIEF LEGAL OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 62,850 shares of CTKB, which is worth approximately $355,731. The most recent transaction as insider was on Nov 18, 2024, when has been sold 4,499 shares (Common Stock) at a price of $6.03 per share, resulting in proceeds of $27,128. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.9K

16.57% 3M change

96.76% 12M change

Total Value Held $355,731

Valerie Barnett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Payment of exercise price or tax liability	$27,128 $6.03 p/Share	4,499 Reduced 6.68%	62,850 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	-	13,432 Added 17.03%	65,453 Common Stock
Aug 19 2024	SELL Payment of exercise price or tax liability	$27,904 $5.53 p/Share	5,046 Reduced 8.56%	53,917 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	-	13,432 Added 19.14%	56,743 Common Stock
May 20 2024	SELL Payment of exercise price or tax liability	$22,355 $5.96 p/Share	3,751 Reduced 8.19%	42,044 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	-	9,626 Added 17.93%	44,053 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$13,804 $7.22 p/Share	1,912 Reduced 5.02%	36,169 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	4,908 Added 11.42%	38,081 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$6,586 $8.38 p/Share	786 Reduced 2.31%	33,173 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	2,016 Added 5.6%	33,959 Common Stock
Nov 18 2023	SELL Payment of exercise price or tax liability	$13,275 $5.98 p/Share	2,220 Reduced 6.5%	31,943 Common Stock
Nov 18 2023	BUY Exercise of conversion of derivative security	-	5,697 Added 14.58%	33,377 Common Stock
Aug 18 2023	SELL Payment of exercise price or tax liability	$18,781 $8.46 p/Share	2,220 Reduced 7.23%	28,466 Common Stock
Aug 18 2023	BUY Exercise of conversion of derivative security	-	5,697 Added 16.0%	29,900 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$11,653 $6.69 p/Share	1,742 Reduced 7.02%	23,070 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	-	4,470 Added 15.69%	24,026 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$8,622 $10.97 p/Share	786 Reduced 3.72%	20,342 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	2,016 Added 8.71%	21,128 Common Stock
Nov 18 2022	SELL Payment of exercise price or tax liability	$11,593 $14.75 p/Share	786 Reduced 3.95%	19,111 Common Stock
Nov 18 2022	BUY Exercise of conversion of derivative security	-	2,016 Added 9.2%	19,897 Common Stock
Aug 18 2022	SELL Payment of exercise price or tax liability	$11,051 $14.06 p/Share	786 Reduced 4.21%	17,881 Common Stock
Aug 18 2022	BUY Exercise of conversion of derivative security	-	2,016 Added 9.75%	18,667 Common Stock
May 18 2022	SELL Payment of exercise price or tax liability	$10,104 $9.65 p/Share	1,047 Reduced 6.94%	14,041 Common Stock
May 18 2022	BUY Exercise of conversion of derivative security	-	2,688 Added 15.12%	15,088 Common Stock
Mar 04 2022	BUY Exercise of conversion of derivative security	$49,455 $4.71 p/Share	10,500 Added 45.85%	12,400 Common Stock

Valerie Barnett

CHIEF LEGAL OFFICER

Fremont, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Value

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB

Account